Protalix Biotherapeutics
Price & Volume
Stats
See more52W Range | $1.32-$3.10 |
Market Cap | $166.4M |
Shares Short | 4M |
Financials
See moreRevenue (12 Mos) | $61.8M |
Revenue Growth (YoY) | -0.6% |
Gross Profit (12 Mos) | $35.5M |
Diluted EPS | $0.08 |
News
See moreYahoo Finance • 2 months ago
PLX Investors Have Opportunity to Join Protalix BioTherapeutics, Inc. Fraud Investigation with the Schall Law Firm
Yahoo Finance • 3 months ago
Vantage Drilling International Ltd. – Announcement of Contract Termination
Yahoo Finance • 3 months ago
Chiesi Global Rare Diseases and Protalix Biotherapeutics Acknowledge CHMP Negative Opinion on Every Four Week Dosing Regimen of Elfabrio® (pegunigalsidase alfa) in the EU
Yahoo Finance • 3 months ago
MPLX LP (MPLX) Price Target Cut Slightly, Rating Stays ‘Overweight’
About
CEO | Mr. Dror Bashan |
CFO | Mr. Gilad Mamlok |
Address | 2 University Plaza, Hackensack, NJ, United States, 07601 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 213 |
